文献速递肾癌与肾肿瘤

衰弱与肾细胞癌:将综合老年评估整合到共享决策中

Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into Shared Decision-making.
PubMed 文献 · Eur Urol Oncol · 2024-09-20

本文是一篇叙述性综述,概述衰弱评估在老年肾肿块/肾细胞癌(RCC)患者管理中的作用,聚焦其对诊断检查、治疗决策和临床结局的影响。衰弱是不良预后因素,可影响局限性和转移性RCC的决策;G8和Mini-COG等筛查工具可帮助临床医生选择年龄≥65岁的老年患者进行由老年科医生完成的综合老年评估(CGA),CGA提供风险分层并指导后续治疗路径。作者提出将老年科医生纳入多学科肿瘤委员会是重要优先事项,并提出一条专用照护路径作为在RCC临床实践和研究中实施衰弱评估的第一步关键步骤。

要点

  • 衰弱是不良预后因素,可影响局限性和转移性RCC的决策。
  • G8和Mini-COG等筛查工具可帮助选择年龄≥65岁患者进行CGA。
  • CGA由老年科医生完成,提供风险分层并指导后续治疗路径。

核心结论

  • 衰弱已成为影响老年RCC患者管理和结局的关键因素,将老年科医生纳入诊断和治疗路径是一种务实的方法,可筛查和评估衰弱,促进基于整体患者风险分层的个体化治疗决策。

研究设计与样本

  • 本文为叙述性文献综述,聚焦衰弱定义、评估工具及其在老年肿瘤学中的应用,并应用于RCC领域。

主要发现

  • 衰弱是不良预后因素,可影响局限性和转移性RCC的管理决策。
  • G8和Mini-COG等筛查工具可帮助临床医生选择年龄≥65岁的老年患者进行由老年科医生完成的进一步综合老年评估(CGA)。
  • CGA提供风险分层见解并指导后续治疗路径。
  • 将老年科医生纳入多学科肿瘤委员会成为重要优先事项,以解决衰弱患者的复杂需求并优化临床结局。

关键数值与推荐

  • 筛查工具如老年筛查工具8(G8)和Mini-COG测试可帮助选择年龄≥65岁的老年患者进行CGA。
  • CGA由专门的老年科医生完成。

临床怎么用

  • 作者提出一条专用照护路径作为在RCC临床实践和研究中实施衰弱评估的第一步关键步骤。
  • 作者认为将老年科医生纳入诊断和治疗路径是一种务实的方法,可筛查和评估衰弱,促进基于整体患者风险分层的个体化治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Frailty, a geriatric syndrome characterized by decreased resilience and physiological reserve, impacts the prognosis and management of older adults significantly, particularly in the context of surgical and oncological care. OBJECTIVE: To provide an overview of frailty assessment in the management of older patients with a renal mass/renal cell carcinoma (RCC), focusing on its implications for diagnostic workup, treatment decisions, and clinical outcomes. EVIDENCE ACQUISITION: A narrative review of the literature was conducted, focusing on frailty definitions, assessment tools, and their application in geriatric oncology, applied to the field of RCC. Relevant studies addressing the prognostic value of frailty, its impact on treatment outcomes, and potential interventions were summarized. EVIDENCE SYNTHESIS: Frailty is a poor prognostic factor and can influence decision-making in the management of both localized and metastatic RCC. Screening tools such as the Geriatric Screening Tool 8 (G8) and the Mini-COG test can aid clinicians to select older patients (ie, aged ≥65 yr) for a further comprehensive geriatric assessment (CGA) performed by dedicated geriatricians. The CGA provides insights to risk stratify patients and guide subsequent treatment pathways. As such, the involvement of geriatricians in multidisciplinary tumor boards emerges as an essential priority to address the complex needs of frail patients and optimize clinical outcomes. Herein, we propose a dedicated care pathway as a first key step to implement frailty assessment in clinical practice and research for RCC. CONCLUSIONS: Frailty has emerged as a crucial factor influencing the management and outcomes of older patients with RCC. Involvement of geriatricians in diagnostic and therapeutic pathways represents a pragmatic approach to screen and assess frailty, fostering individualized treatment decisions according to holistic patient risk stratification. PATIENT SUMMARY: Frailty, a decline in resilience and physiological reserve, influences treatment decisions and outcomes in elderly patients with renal cell carcinoma, guiding personalized care. In this review, we focused on pragmatic strategies to screen patients with a renal mass suspected for renal cell carcinoma, who are older than 65 yr, for frailty and on personalized management algorithms integrating geriatric input beyond patient- and tumor-related factors.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Pecoraro A, Testa GD, Marandino L, et al. Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into Shared Decision-making. Eur Urol Oncol. 2024. PMID: 39306584. doi:10.1016/j.euo.2024.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。